2020
DOI: 10.1136/bmjspcare-2019-002126
|View full text |Cite
|
Sign up to set email alerts
|

NECPAL tool prognostication in advanced chronic illness: a rapid review and expert consensus

Abstract: ObjectiveTo develop a proposal for a 2-year mortality prognostic approach for patients with advanced chronic conditions based on the palliative care need (PCN) items of the NECesidades PALiativas (NECPAL) CCOMS-ICO V.3.1 2017 tool.MethodsA phase 1 study using three components based on the NECPAL items: (1) a rapid review of systematic reviews (SRs) on prognostic factors of mortality in patients with advanced chronic diseases and PCNs; (2) a clinician and statistician experts' consensus based on the Delphi tech… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 23 publications
(21 citation statements)
references
References 45 publications
0
18
0
3
Order By: Relevance
“…In contrast, the availability of validated screening instruments enabled the identification of ACPs based on a robust construct. In our setting, the NECPAL tool, a validated instrument for the early identification of the need for palliative care among individuals with limited life expectancy, is routinely used [ 26 , 40 , 41 ]. Despite differences in the application of the concept of palliative care among countries (i.e., patients with oncologic conditions and in the last weeks or days of life vs. management of advanced chronic conditions), the definition of ACPs included in the Catalan healthcare plan used a robust method for identification, similar to other countries, potentially enabling comparisons among different countries/settings.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, the availability of validated screening instruments enabled the identification of ACPs based on a robust construct. In our setting, the NECPAL tool, a validated instrument for the early identification of the need for palliative care among individuals with limited life expectancy, is routinely used [ 26 , 40 , 41 ]. Despite differences in the application of the concept of palliative care among countries (i.e., patients with oncologic conditions and in the last weeks or days of life vs. management of advanced chronic conditions), the definition of ACPs included in the Catalan healthcare plan used a robust method for identification, similar to other countries, potentially enabling comparisons among different countries/settings.…”
Section: Discussionmentioning
confidence: 99%
“…NECPAL’s predictive validity had already been tested in a Spanish cohort of a prevalence study, with high sensitivity and negative predictive value but limited specificity in predicting 24-month death [ 22 ]. Later, some NECPAL parameters have been independently associated with mortality risk in different populations [ 23 ]. In a previous study, we constructed a predictive model in one of the current Argentinian hospitals to identify individuals with PC needs for 24 months [ 8 ].…”
Section: Discussionmentioning
confidence: 99%
“…24 26-28 EOLp were identified using the NECPAL (NECesidades PALiativas, palliative care needs) tool, a validated tool for the early identification of the need for palliative care among individuals with limited life expectancy. [29][30][31] EOLp were classified into the three archetypal end-of-life trajectories according to the severity and/or progression criteria for their main underlying disease: cancer, organ failure (including chronic pulmonary disease, chronic heart disease, serious chronic liver disease and serious chronic renal disease) and dementia (including other chronic neurological diseases). People with palliative care needs without a predominant advanced disease were identified as 'multimorbidity' group or trajectory, since all had two or more underlying chronic conditions.…”
Section: Variables and Data Sourcesmentioning
confidence: 99%